1+ day, 16+ hour ago   (95+ words) The Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and Family Welfare, Government of India, organized a two-day National Conference on “Quality and Safety of Biosimilars: Strengthening India’s Biopharma SHAKTI Vision” on September 10–11, 2026, at the Centre…...

1+ day, 14+ hour ago   (312+ words) Kumar is a business transformation leader with more than two decades of experience across multiple industries and geographies Sunil Kumar has been elevated to Chief Operations Officer (COO) at Jubilant HollisterStier Allergy, where he will focus on strengthening the company’s…...

1+ day, 15+ hour ago   (189+ words) Malpure comes with over 17 years of experience in pharmaceutical product management and marketing Bhushan Malpure has been elevated to Head of Marketing at Cipla, marking another step in his pharmaceutical marketing career with the company. Malpure has held several key…...

1+ day, 16+ hour ago   (345+ words) Johnson & Johnson has received the CE Mark for its ACUVUE OASYS MAX 2-Week reusable contact lens, featuring the company’s MAX technologies, paving the way for its introduction in select European markets later this year. The lens is expected to launch…...

4+ day, 14+ hour ago   (553+ words) The new entity focused on development and commercial manufacturing services for complex molecules will operate separately from its parent company’s corporate identity Shilpa Medicare is set to launch Shilpa CDMO, a dedicated contract development and manufacturing organisation focused on complex…...

4+ day, 21+ hour ago   (430+ words) Sahajanand Medical Technologies Limited (SMT) has received a Class IV medical device licence from Health Canada’s Medical Devices Directorate for its Supraflex Cruz sirolimus-eluting coronary stent system, marking the company’s entry into the Canadian market. The family licence covers the…...

6+ day, 2+ hour ago   (65+ words) Over the past year, the supply of FDA-approved estradiol transdermal patches has nearly doubled FDA moves to boost estradiol patch supply as demand surges Superluminal Medicines raises $60 million to push obesity drug into clinic Novartis’ pelacarsen trial fails to cut…...

6+ day, 1+ hour ago   (256+ words) Biocon Limited has signed a landmark partnership agreement with Bahiafarma and Bionovis for Pertuzumab in Brazil. This collaboration marks a significant step forward in scaling the production and commercialization of this HER2-positive breast cancer therapy under the country's Productive Development…...

6+ day, 4+ hour ago   (54+ words) The pivotal cardiovascular outcomes trial did not meet its primary endpoint FDA moves to boost estradiol patch supply as demand surges Superluminal Medicines raises $60 million to push obesity drug into clinic Novartis’ pelacarsen trial fails to cut cardiovascular risk Indian…...

1+ week, 6+ hour ago   (64+ words) The US Food and Drug Administration’s accelerated approval is based on results from the Phase III SERENA-6 trial Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership…...